News
All NewsContributorsMoney Matters
Media
All VideosExpert InterviewsMedical World NewsPodcastsCase Based Roundtable SeriesCase of the QuarterEyeViewGrand RoundsInsightsRapid ReadoutViewpointsWhat’s Your WhEYE?
Conferences
Conference CoverageConference Listing
Events
More
Publications
Digital EditionEurope Ophthalmology TimesModern RetinaSupplements and Featured Publications
CME
Partners
Resources
Job BoardSponsored

Subscribe

  • News
    • All News
    • Contributors
    • Money Matters
  • Media
    • Conferences
      • Events
      • Publications
        • CME
        • Partners
        • Subscribe
        • Resources
          • AMD
          • Biosimilars
          • COVID-19
          • Cataract
            • Cataract Surgery
          • Cataract Therapeutics
          • Clinical Diagnosis
            • The Residency Report
            • iOpeners
            • NeuroOp Guru
          • Cornea
          • DME
          • Dry Eye
            • Dry Eye Awareness
          • Gene Therapy
          • Geographic Atrophy
          • IOL
            • IOL Advances
          • Imaging
          • Interventional Glaucoma
            • Glaucoma Awareness
            • Glaucoma Insights
            • Therapeutic Glaucoma
          • OCT
          • Ocular Allergy
          • Ocular Surface Disease
          • Optic Relief
          • Optometry
          • Pediatrics
          • Pharmacy
          • Practice Management
            • Indispensable
          • Presbyopia
          • Ptosis
          • Refractive
            • Refractive Surgery
          • Retina
          • Surgery
          • Technology
          • Therapeutics
          • Understanding Antibiotic Resistance
          • Workplace
          Spotlight -
          Retina
          Advertisement

          Abigail T. Fahim, MD, PhD

          Advertisement

          Articles by Abigail T. Fahim, MD, PhD

          (Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points

          The Residency Report: Study provides new insights into USH2A target end points

          ByJoseph Colcombe, MD,Nitish Mehta, MD,Abigail T. Fahim, MD, PhD
          April 30th 2025

          Researchers evaluate key measures for tracking disease progression in Usher syndrome type 2–related retinal degeneration

          Advertisement

          Latest Updated Articles

          • (Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
            The Residency Report: Study provides new insights into USH2A target end points

            Published: April 30th 2025 | Updated:



          Advertisement
          Advertisement

          Trending on Ophthalmology Times - Clinical Insights for Eye Specialists

          1

          Idebenone accepted by FDA for priority review for Leber Hereditary Optic Neuropathy

          2

          Luxa Biotechnology announces clinical trial results for treatment of AMD

          3

          STAAR Surgical confirms expiration of “window shop” period in Alcon merger agreement

          4

          The European Commission grants marketing authorization for EYLUXVI

          5

          Palatin recieves $6.5 million milestone payment from partnership with Boehringer Ingelheim

          • About
          • Advertise
          • Privacy
          • Editorial Info
          • Editorial Board
          • Terms and Conditions
          • Contact Us
          • Do Not Sell My Personal Information
          • Job Board
          Contact Info

          259 Prospect Plains Rd, Bldg H
          Monroe, NJ 08831

          609-716-7777

          • Ophthalmology Times
          • Modern Retina
          • Optometry Times
          • Ophthalmology Times Europe
          EyeCare Network
          Brand Logo

          © 2025 MJH Life Sciences®

          All rights reserved.

          Home
          About Us
          News
          Contact Us